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Protein Segregation Mysteries in
iPSCsMitochondrial diseases cause a range of clinical manifestations even in
patients carrying the samemtDNAmutations. Newwork reveals that a common
disease-associated mtDNA mutation is selectively segregated from wild-type
mtDNA during the reprogramming of induced pluripotent stem cells and that
high levels of this mutation in differentiated neurons upregulate
Parkin-mediated mitophagy.Alicia M. Pickrell
and Richard J. Youle*
Multiple copies of mitochondrial DNA
(mtDNA) reside in mitochondria and
this DNA encodes the tRNA and rRNA
machinery required to translate 13
components of all of the complexes of
the respiratory chain, except complex
II. Mutations in the mtDNA that affect
oxidative phosphorylation function are
common; it is estimated that 1 in 5,000
children and adults have mitochondrial
diseases caused by mtDNA mutations
[1]. MtDNA mutations reach varying
levels of heteroplasmy — the ratio
of wild-type to mutated mtDNA
molecules — in different tissues and
present a wide range of clinical
symptoms, even between patients
harboring the same type of mutation.
The most common mtDNA mutation,
m.3243A>G, disrupts the gene
encoding tRNA Leucine(UUR) and
causes two distinct mitochondrial
diseases: maternally inherited
diabetes and deafness (MIDD) and
mitochondrial encephalomyopathy,
lactic acidosis, and stroke-likeepisodes (MELAS) [1]. To date, the
most puzzling question is how mtDNA
mutations affect different cell types to
cause different phenotypes and how
mutational load is determined in
different tissues. Recent work by
Ha¨ma¨la¨inen et al. [2], published in
Proceedings of the National Academy
of Sciences, used an induced
pluripotent stem cell (iPSC) model to
provide mechanistic insight into how
mtDNA mutations affect neurons
differently from other cell types and
how mtDNA mutations segregate in
iPSCs to affect their differentiated
progeny.
This study fromSuomalainen’s group
shows that the m.3243A>G mutation
causes a defect in respiratory chain
complex I in differentiated neurons, but
has no detrimental effect on oxidative
phosphorylation activity in iPSCs [2].
Disrupting the proof-reading domain of
the nuclear gene polymerase g, which
controls mtDNA replication, causes an
accelerated accumulation of mtDNA
mutations in a premature agingMutator
mouse model. These mtDNAmutations
impactmitochondrial functionwith age,causing Mutator mice to suffer from
weight loss, cardiomyopathies,
age-related muscle wasting, fur
graying, and other phenotypes that
mimic human aging [3,4]. Prior work
from the Suomalainen group showed
that high mtDNA mutational loads in
neural stem cells (NSCs) from Mutator
mice do not result in a respiratory
defect, but lead to oxidative
phosphorylation dysfunction in adult
neurons later in life [5]. MtDNA
mutations in iPSCsorNSCsdonot have
the same adverse effects on oxidative
phosphorylation activity as in other cell
types, likely due to the heavy reliance of
these stem cells on glycolysis for
energy metabolism [6]. However,
mtDNA mutations negatively affect the
survival and proliferative abilities of
stem cells, possibly due to alternative
signaling pathways, such as the
generation of reactive oxygen species
[5]. It remains mysterious how a tRNA
Leucine(UUR) mutation selectively
impairs complex I in post-mitotic
neurons when it is needed for the
translation of all mitochondrial genes.
Neurons are complex specialized
cell types categorized by location
and by the type of neurotransmitters
they release. Often, this view itself is
simplistic; for example, different
subtypes of dopaminergic neurons
express different calcium-binding
proteins and have distinct baseline
neuronal firing oscillations. This
is important because different
disruptions in mtDNA integrity
cause divergent neuroanatomical
susceptibilities in the central nervous
system [7]. Knocking out the function of
complex III or complex IV in the same




Figure 1. mtDNA bottleneck for tRNA mutations during iPSC differentiation.
Patient skin fibroblasts harbor a mutant mtDNA content of approximately 30%. During induced
pluripotency, mtDNA copy number rises, shifting heteroplasmy to reach levels closer to
homoplasmy in the direction of either mostly wild-type or mostly mutant molecules. The shift
towards homoplasmy is permanent after differentiation.
Dispatch
R1053subset of neurons expressing calcium/
calmodulin-dependent protein kinase
IIa(CaMKIIa) causes distinct patterns
of neurodegeneration, resulting in
dissimilar phenotypical consequences
[8]. While future work will explore
how different neuronal subtypes are
dependent on mitochondrial function,
it is noteworthy that Ha¨ma¨la¨inen et al.
[2] report that mtDNA mutations
cause distinct types of mitochondrial
dysfunction and compensation
mechanisms that are unique to
neurons.
Pharmacological and genetic
knockout models that dissipate the
mitochondrial membrane potential
(Dcm) have supported the idea
that Parkin, an E3 ubiquitin ligase,
is recruited to dysfunctional
mitochondria to target the whole
organelle for autophagic engulfment
and removal — a process termed
mitophagy [9]. Ha¨ma¨la¨inen et al. [2]
demonstrate that Parkin recruitment
and LC3 lipidation (a protein
modification that indicates the
induction of autophagy) specifically
target the faulty complex I components
for removal in m.3243A>G
differentiated neurons. In agreement
with this finding, specific respiratory
complex proteins are subject to
selective turnover in Drosophila brain
mitochondria and this turnover is
impeded in Parkin- and autophagy-
deficient fly models [10]. Owing to the
high respiratory demands of neurons
for survival and physiological function,
the complete removal of dysfunctional
mitochondria may be energetically
costly. In fact, cells attempt to
compensate for inherited oxidative
phosphorylation defects by an increase
in mitochondrial proliferation [11]. It
would be paradoxical to generate new
mitochondria for destruction, so the
selective removal of damaged
oxidative phosphorylation complexes
fromotherwise functional mitochondria
may yield a refined quality control
mechanism that may also occur in
other cell types harboring mtDNA
mutations. In support of this idea,
differentiated neurons generated from
heteroplasmic iPSCs harboring mtDNA
mutations in the COXI and ND5/ND6
genes disrupting complex IV and
complex I, respectively, were able to
maintain Dcm, even in the context
of a severe loss of oxidative
phosphorylation [12]. Thus, the
depolarization of mitochondria cannot
be the only way to alert the cell thatmitochondria are dysfunctional.
Consistent with this idea, accumulation
of misfolded proteins inside
mitochondria can trigger Parkin-
mediated mitophagy without
membrane depolarization [13]. How
damaged subsets of mitochondrial
proteins can be segregated for
selective disposal remains to be
elucidated.
Finally, this study shows that
reprogramming of somatic cells to
iPSCs segregates heteroplasmic
mtDNA mutations differently than in
somatic cells, as the m.3243A>G
mutation preferentially shifts towards
homoplasmy, populating iPSCs with
either mainly mutant or mainly
wild-type mtDNA molecules (Figure 1)
[2]. It appears that cells undergo
a genetic bottleneck during
dedifferentiation, similar to mtDNA in
the female germ line during oogenesis
[14]. Contrary to the belief that mtDNA
levels are reduced to generate a
physical genetic bottleneck to
preferentially select one mtDNA variant
over another, Ha¨ma¨la¨inen et al. [2]
show that mtDNA levels are increased
in iPSCs harboring mtDNA mutations
during this reprogramming [14]. This
new study confirms that mtDNA
mutational selection occurs during the
acquisition of stem cell fate, although
we do not understand how this occurs.
This genetic selection and increase in
mtDNA levels appears to differ in iPSCswith wild-type mtDNA, as the levels of
mtDNA drop as mitochondrial content
is reduced, owing to the lack of
demand during anaerobic metabolism
[15]. These data also could explain the
severe mitochondrial defects found in
healthy aged human colon crypts that
arise from mtDNA mutations in the
crypt stem cells, which pass these
mutations to their differentiated
progeny [16]. Heart, skeletal muscle,
and the central nervous system are the
most affected tissues in mitochondrial
disease patients. It was thought that,
due to their post-mitotic state and low
cell turnover, these tissues retained
high levels of mutant mtDNA. Given the
findings reported in this new study, it
is possible that the regenerative stem
cell pools in these tissues could also
contribute to mtDNA mutant load. Yet,
it is important to verify that this genetic
bottleneck does not only occur during
experimental reprogramming and that
this heteroplasmic shift occurs in
natural stem cell pools.
The work of Ha¨ma¨la¨inen et al.
[2] provides us with a deeper
understanding of mtDNA biology
in different cell types and gives
insight into how mtDNA mutations
are transmitted and lead to
pathophysiological consequences.
This powerful model, using these
m.3243A>G iPSCs, can be used to
investigate whether other post-mitotic
cell types, such as skeletal muscle, also
Current Biology Vol 23 No 23
R1054show distinct phenotypes from the
parental fibroblast line.
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DigitalWhy do some genes seem to respond in a ‘digital’, on/off manner to a graded
signal, while others produce an ‘analog’, graded response? A new study
suggests that the DNA-binding properties of transcription factors can strongly
influence the response patterns of gene networks.David S. Lorberbaum
and Scott Barolo*
Cells frequently need to change their
gene expression profiles in response to
external stimuli such as environmental
stresses or developmental patterning
signals. This is accomplished mainly
through cis-regulatory DNA
sequences, which contain binding sites
for transcription factors, proteins with
gene regulatory activities and binding
preferences for specific DNA motifs.
Signals received by the cell alter the
abundance or activity of certain
transcription factors, which directly
activate or repress expression of
specific target genes. Some signals
require a sharp on/off response when a
threshold has been reached, whileothers call for a graded response that is
proportional to the intensity of the
signal. A new study reported in
this issue of Current Biology by
Stewart-Ornstein et al. [1] addresses
how these different transcriptional
responses can be encoded in the
genome.
Many transcription factors have long
been known to bindDNAcooperatively,
and/or to activate transcription in a
highly synergistic manner, by diverse
in vitro and in vivo assays [2–8].
Synergy among transcriptional
activators is often essential for
describing precise patterns of gene
expression in multicellular organisms
[9–12]. For example, in the Drosophila
embryo, the Bicoid morphogen is
proposed to create sharp boundariesof target gene expression through its
high transcriptional cooperativity
[5,7,13] (but see [14] for a fascinating
update to that story). Countless
developmental enhancers have been
shown to rely on cooperative activation
to integrate graded signals into
seemingly ‘digital’ on/off patterns of
gene expression [10,15].
Sometimes, however, a proportional
response is called for. For example,
the expression levels of many yeast
genes are linearly correlated with
growth rate [16]. Cell–cell signaling
pathways, such as the pheromone
response system in yeast and
developmental patterning pathways in
animals and plants, often employ
negative feedback mechanisms to
produce transcriptional responses in
proportion to the intensity of the signal
[17,18]. Cellular responses to stress
and other environmental inputs are also
typically ‘analog’ in the sense that the
level of transcriptional response
increases with the amount of stimulus.
A 2010 study of the transcription factor
NF-kB suggested that non-cooperative
DNA binding to clusters of sites in
target enhancers underlies its ability
